ID   STK26_HUMAN             Reviewed;         416 AA.
AC   Q9P289; B2RAU2; Q3ZB77; Q8NC04; Q9BXC3; Q9BXC4;
DT   16-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2001, sequence version 2.
DT   12-OCT-2022, entry version 179.
DE   RecName: Full=Serine/threonine-protein kinase 26 {ECO:0000305};
DE            EC=2.7.11.1 {ECO:0000269|PubMed:11641781, ECO:0000269|PubMed:29232556};
DE   AltName: Full=MST3 and SOK1-related kinase {ECO:0000303|PubMed:11741893};
DE   AltName: Full=Mammalian STE20-like protein kinase 4 {ECO:0000303|PubMed:11641781};
DE            Short=MST-4 {ECO:0000305};
DE            Short=STE20-like kinase MST4 {ECO:0000305};
DE   AltName: Full=Serine/threonine-protein kinase MASK {ECO:0000305};
GN   Name=STK26 {ECO:0000312|HGNC:HGNC:18174};
GN   Synonyms=MASK {ECO:0000303|PubMed:11741893}, MST4
GN   {ECO:0000303|PubMed:11641781};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=11641781; DOI=10.1038/sj.onc.1204818;
RA   Lin J.-L., Chen H.-C., Fang H.-I., Robinson D., Kung H.-J., Shih H.-M.;
RT   "MST4, a new Ste20-related kinase that mediates cell growth and
RT   transformation via modulating ERK pathway.";
RL   Oncogene 20:6559-6569(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Fetal brain;
RX   PubMed=11306563; DOI=10.1074/jbc.m009323200;
RA   Qian Z., Lin C., Espinosa R., LeBeau M., Rosner M.R.;
RT   "Cloning and characterization of MST4, a novel Ste20-like kinase.";
RL   J. Biol. Chem. 276:22439-22445(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=11741893; DOI=10.1074/jbc.m110882200;
RA   Dan I., Ong S.E., Watanabe N.M., Blagoev B., Nielsen M.M., Kajikawa E.,
RA   Kristiansen T.Z., Mann M., Pandey A.;
RT   "Cloning of MASK, a novel member of the mammalian germinal center kinase
RT   III subfamily, with apoptosis-inducing properties.";
RL   J. Biol. Chem. 277:5929-5939(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION AT THR-178, INTERACTION WITH GOLGA2,
RP   AND ACTIVITY REGULATION.
RX   PubMed=15037601; DOI=10.1083/jcb.200310061;
RA   Preisinger C., Short B., De Corte V., Bruyneel E., Haas A., Kopajtich R.,
RA   Gettemans J., Barr F.A.;
RT   "YSK1 is activated by the Golgi matrix protein GM130 and plays a role in
RT   cell migration through its substrate 14-3-3zeta.";
RL   J. Cell Biol. 164:1009-1020(2004).
RN   [10]
RP   INTERACTION WITH PDCD10, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17360971; DOI=10.1091/mbc.e06-07-0608;
RA   Ma X., Zhao H., Shan J., Long F., Chen Y., Chen Y., Zhang Y., Han X.,
RA   Ma D.;
RT   "PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and
RT   transformation via modulation of the ERK pathway.";
RL   Mol. Biol. Cell 18:1965-1978(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4 AND THR-178, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-300; SER-304 AND SER-306, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   INTERACTION WITH PDCD10.
RX   PubMed=19370760; DOI=10.1002/humu.20996;
RA   Voss K., Stahl S., Hogan B.M., Reinders J., Schleider E.,
RA   Schulte-Merker S., Felbor U.;
RT   "Functional analyses of human and zebrafish 18-amino acid in-frame deletion
RT   pave the way for domain mapping of the cerebral cavernous malformation 3
RT   protein.";
RL   Hum. Mutat. 30:1003-1011(2009).
RN   [14]
RP   INTERACTION WITH CTTNBP2NL.
RX   PubMed=18782753; DOI=10.1074/mcp.m800266-mcp200;
RA   Goudreault M., D'Ambrosio L.M., Kean M.J., Mullin M.J., Larsen B.G.,
RA   Sanchez A., Chaudhry S., Chen G.I., Sicheri F., Nesvizhskii A.I.,
RA   Aebersold R., Raught B., Gingras A.C.;
RT   "A PP2A phosphatase high density interaction network identifies a novel
RT   striatin-interacting phosphatase and kinase complex linked to the cerebral
RT   cavernous malformation 3 (CCM3) protein.";
RL   Mol. Cell. Proteomics 8:157-171(2009).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-4; THR-178 AND SER-300, CLEAVAGE OF INITIATOR METHIONINE
RP   [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-178, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   INTERACTION WITH PDCD10 AND GOLGA2, AND SUBCELLULAR LOCATION.
RX   PubMed=20332113; DOI=10.1242/jcs.061341;
RA   Fidalgo M., Fraile M., Pires A., Force T., Pombo C., Zalvide J.;
RT   "CCM3/PDCD10 stabilizes GCKIII proteins to promote Golgi assembly and cell
RT   orientation.";
RL   J. Cell Sci. 123:1274-1284(2010).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-4, CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE
RP   ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-4; SER-300; SER-304 AND SER-306, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; THR-178; SER-325; THR-327
RP   AND THR-328, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [24]
RP   FUNCTION, INTERACTION WITH RIPOR1, AND SUBCELLULAR LOCATION.
RX   PubMed=27807006; DOI=10.1242/jcs.198614;
RA   Mardakheh F.K., Self A., Marshall C.J.;
RT   "RHO binding to FAM65A regulates Golgi reorientation during cell
RT   migration.";
RL   J. Cell Sci. 129:4466-4479(2016).
RN   [25]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF LYS-53.
RX   PubMed=29232556; DOI=10.1016/j.ccell.2017.11.005;
RA   Huang T., Kim C.K., Alvarez A.A., Pangeni R.P., Wan X., Song X., Shi T.,
RA   Yang Y., Sastry N., Horbinski C.M., Lu S., Stupp R., Kessler J.A.,
RA   Nishikawa R., Nakano I., Sulman E.P., Lu X., James C.D., Yin X.M., Hu B.,
RA   Cheng S.Y.;
RT   "MST4 phosphorylation of ATG4B regulates autophagic activity,
RT   tumorigenicity, and radioresistance in glioblastoma.";
RL   Cancer Cell 32:840-855(2017).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 1-300 IN COMPLEX WITH QUINAZOLIN
RP   INHIBITOR, AND SUBUNIT.
RX   PubMed=20730082; DOI=10.1371/journal.pone.0011905;
RA   Record C.J., Chaikuad A., Rellos P., Das S., Pike A.C., Fedorov O.,
RA   Marsden B.D., Knapp S., Lee W.H.;
RT   "Structural comparison of human mammalian ste20-like kinases.";
RL   PLoS ONE 5:E11905-E11905(2010).
RN   [27]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-9; TRP-36 AND CYS-45.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase that acts as a mediator of
CC       cell growth (PubMed:11641781, PubMed:17360971). Modulates apoptosis
CC       (PubMed:11641781, PubMed:17360971). In association with STK24
CC       negatively regulates Golgi reorientation in polarized cell migration
CC       upon RHO activation (PubMed:27807006). Phosphorylates ATG4B at 'Ser-
CC       383', thereby increasing autophagic flux (PubMed:29232556).
CC       {ECO:0000269|PubMed:11641781, ECO:0000269|PubMed:17360971,
CC       ECO:0000269|PubMed:27807006, ECO:0000269|PubMed:29232556}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:11641781, ECO:0000269|PubMed:29232556};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:11641781};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y4P1};
CC   -!- ACTIVITY REGULATION: Interaction with Golgi matrix protein GOLGA2 leads
CC       to autophosphorylation on Thr-178, possibly as a consequence of
CC       stabilization of dimer formation. May also be activated by C-terminal
CC       cleavage. {ECO:0000269|PubMed:15037601}.
CC   -!- SUBUNIT: Homodimer (PubMed:20730082). Interacts with PDCD10
CC       (PubMed:17360971, PubMed:19370760, PubMed:20332113). Interacts with
CC       GOLGA2 (PubMed:15037601, PubMed:20332113). Interacts with CTTNBP2NL
CC       (PubMed:18782753). Interacts with RIPOR1 (via C-terminus); this
CC       interaction occurs in a PDCD10-dependent and Rho-independent manner
CC       (PubMed:27807006). Interacts with PDCD10; this interaction is required
CC       for the association of STK26 with RIPOR1 (PubMed:27807006).
CC       {ECO:0000269|PubMed:15037601, ECO:0000269|PubMed:17360971,
CC       ECO:0000269|PubMed:18782753, ECO:0000269|PubMed:19370760,
CC       ECO:0000269|PubMed:20332113, ECO:0000269|PubMed:20730082,
CC       ECO:0000269|PubMed:27807006}.
CC   -!- INTERACTION:
CC       Q9P289; Q9Y376: CAB39; NbExp=6; IntAct=EBI-618239, EBI-306905;
CC       Q9P289; Q9P2B4: CTTNBP2NL; NbExp=5; IntAct=EBI-618239, EBI-1774273;
CC       Q9P289; Q08379: GOLGA2; NbExp=6; IntAct=EBI-618239, EBI-618309;
CC       Q9P289; Q9BUL8: PDCD10; NbExp=8; IntAct=EBI-618239, EBI-740195;
CC       Q9P289; Q9P289: STK26; NbExp=4; IntAct=EBI-618239, EBI-618239;
CC       Q9P289; Q5VSL9: STRIP1; NbExp=3; IntAct=EBI-618239, EBI-1773588;
CC       Q9P289-1; Q9Y376: CAB39; NbExp=10; IntAct=EBI-15996971, EBI-306905;
CC       Q9P289-1; Q9BUL8: PDCD10; NbExp=10; IntAct=EBI-15996971, EBI-740195;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17360971,
CC       ECO:0000269|PubMed:27807006}. Golgi apparatus
CC       {ECO:0000269|PubMed:15037601, ECO:0000269|PubMed:27807006}.
CC       Note=Colocalized with RIPOR1 in the Golgi of serum-starved cells and
CC       relocated to cytoplasmic punctae, probably vesicular compartments,
CC       along with RIPOR1 upon serum stimulation in a Rho- and PDCD10-dependent
CC       manner (PubMed:27807006). {ECO:0000269|PubMed:27807006}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9P289-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9P289-2; Sequence=VSP_041469;
CC       Name=3; Synonyms=MST4a;
CC         IsoId=Q9P289-3; Sequence=VSP_041470;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF231012; AAK38484.1; -; mRNA.
DR   EMBL; AF344882; AAK29620.1; -; mRNA.
DR   EMBL; AF344883; AAK29621.1; -; mRNA.
DR   EMBL; AB040057; BAA92785.2; -; mRNA.
DR   EMBL; BT020099; AAV38902.1; -; mRNA.
DR   EMBL; AK075107; BAC11406.1; -; mRNA.
DR   EMBL; AK314356; BAG36989.1; -; mRNA.
DR   EMBL; AL109749; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471107; EAX11786.1; -; Genomic_DNA.
DR   EMBL; CH471107; EAX11787.1; -; Genomic_DNA.
DR   EMBL; BC098315; AAH98315.1; -; mRNA.
DR   EMBL; BC103503; AAI03504.1; -; mRNA.
DR   CCDS; CCDS14631.1; -. [Q9P289-1]
DR   CCDS; CCDS43995.1; -. [Q9P289-3]
DR   CCDS; CCDS48168.1; -. [Q9P289-2]
DR   RefSeq; NP_001035917.1; NM_001042452.1. [Q9P289-3]
DR   RefSeq; NP_001035918.1; NM_001042453.1. [Q9P289-2]
DR   RefSeq; NP_057626.2; NM_016542.3. [Q9P289-1]
DR   PDB; 3GGF; X-ray; 2.35 A; A/B=1-300.
DR   PDB; 3W8I; X-ray; 2.40 A; B=346-416.
DR   PDB; 4FZA; X-ray; 3.15 A; B=18-297.
DR   PDB; 4FZD; X-ray; 3.25 A; B=18-297, C=323-327.
DR   PDB; 4FZF; X-ray; 3.64 A; B=18-297.
DR   PDB; 4GEH; X-ray; 1.95 A; B/D=325-413.
DR   PDB; 5XY9; X-ray; 2.30 A; C/D=314-325.
DR   PDB; 5YF4; X-ray; 1.90 A; B=320-335.
DR   PDB; 7B36; X-ray; 2.11 A; A/C=1-300.
DR   PDBsum; 3GGF; -.
DR   PDBsum; 3W8I; -.
DR   PDBsum; 4FZA; -.
DR   PDBsum; 4FZD; -.
DR   PDBsum; 4FZF; -.
DR   PDBsum; 4GEH; -.
DR   PDBsum; 5XY9; -.
DR   PDBsum; 5YF4; -.
DR   PDBsum; 7B36; -.
DR   AlphaFoldDB; Q9P289; -.
DR   SMR; Q9P289; -.
DR   BioGRID; 119722; 193.
DR   DIP; DIP-34049N; -.
DR   IntAct; Q9P289; 51.
DR   MINT; Q9P289; -.
DR   STRING; 9606.ENSP00000377867; -.
DR   BindingDB; Q9P289; -.
DR   ChEMBL; CHEMBL5941; -.
DR   DrugBank; DB07853; 2-[4-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]iminocyclohexa-2,5-dien-1-yl]acetonitrile.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q9P289; -.
DR   GlyGen; Q9P289; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9P289; -.
DR   PhosphoSitePlus; Q9P289; -.
DR   SwissPalm; Q9P289; -.
DR   BioMuta; STK26; -.
DR   DMDM; 73621232; -.
DR   EPD; Q9P289; -.
DR   jPOST; Q9P289; -.
DR   MassIVE; Q9P289; -.
DR   MaxQB; Q9P289; -.
DR   PaxDb; Q9P289; -.
DR   PeptideAtlas; Q9P289; -.
DR   PRIDE; Q9P289; -.
DR   ProteomicsDB; 83756; -. [Q9P289-1]
DR   ProteomicsDB; 83757; -. [Q9P289-2]
DR   ProteomicsDB; 83758; -. [Q9P289-3]
DR   Antibodypedia; 30220; 297 antibodies from 36 providers.
DR   DNASU; 51765; -.
DR   Ensembl; ENST00000394334.7; ENSP00000377867.2; ENSG00000134602.16. [Q9P289-1]
DR   Ensembl; ENST00000394335.6; ENSP00000377868.2; ENSG00000134602.16. [Q9P289-2]
DR   Ensembl; ENST00000496850.1; ENSP00000419702.1; ENSG00000134602.16. [Q9P289-3]
DR   GeneID; 51765; -.
DR   KEGG; hsa:51765; -.
DR   MANE-Select; ENST00000394334.7; ENSP00000377867.2; NM_016542.4; NP_057626.2.
DR   UCSC; uc004ewk.2; human. [Q9P289-1]
DR   CTD; 51765; -.
DR   DisGeNET; 51765; -.
DR   GeneCards; STK26; -.
DR   HGNC; HGNC:18174; STK26.
DR   HPA; ENSG00000134602; Tissue enhanced (bone marrow, epididymis).
DR   MIM; 300547; gene.
DR   neXtProt; NX_Q9P289; -.
DR   OpenTargets; ENSG00000134602; -.
DR   VEuPathDB; HostDB:ENSG00000134602; -.
DR   eggNOG; KOG0201; Eukaryota.
DR   GeneTree; ENSGT00940000157904; -.
DR   HOGENOM; CLU_000288_63_23_1; -.
DR   InParanoid; Q9P289; -.
DR   OrthoDB; 1328688at2759; -.
DR   PhylomeDB; Q9P289; -.
DR   PathwayCommons; Q9P289; -.
DR   Reactome; R-HSA-111465; Apoptotic cleavage of cellular proteins.
DR   SignaLink; Q9P289; -.
DR   SIGNOR; Q9P289; -.
DR   BioGRID-ORCS; 51765; 16 hits in 702 CRISPR screens.
DR   ChiTaRS; STK26; human.
DR   EvolutionaryTrace; Q9P289; -.
DR   GeneWiki; MST4; -.
DR   GenomeRNAi; 51765; -.
DR   Pharos; Q9P289; Tchem.
DR   PRO; PR:Q9P289; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; Q9P289; protein.
DR   Bgee; ENSG00000134602; Expressed in germinal epithelium of ovary and 173 other tissues.
DR   ExpressionAtlas; Q9P289; baseline and differential.
DR   Genevisible; Q9P289; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0071944; C:cell periphery; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0005798; C:Golgi-associated vesicle; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0012506; C:vesicle membrane; TAS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0009267; P:cellular response to starvation; IMP:UniProtKB.
DR   GO; GO:0030033; P:microvillus assembly; IDA:UniProtKB.
DR   GO; GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0042981; P:regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:1903205; P:regulation of hydrogen peroxide-induced cell death; IMP:UniProtKB.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IDA:UniProtKB.
DR   CDD; cd06640; STKc_MST4; 1.
DR   Gene3D; 1.10.12.70; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR046409; PDC10_dimerisation_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR035056; STK_MST4.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Apoptosis; ATP-binding;
KW   Cytoplasm; Golgi apparatus; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692"
FT   CHAIN           2..416
FT                   /note="Serine/threonine-protein kinase 26"
FT                   /id="PRO_0000086404"
FT   DOMAIN          24..274
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          297..340
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        144
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         30..38
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         53
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000305|PubMed:29232556"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692"
FT   MOD_RES         4
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         178
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:15037601,
FT                   ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163"
FT   MOD_RES         300
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:21406692"
FT   MOD_RES         304
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         306
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         309
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99JT2"
FT   MOD_RES         325
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         327
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         328
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         15..91
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_041469"
FT   VAR_SEQ         200..261
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11306563"
FT                   /id="VSP_041470"
FT   VARIANT         9
FT                   /note="Q -> R (in dbSNP:rs56035648)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040844"
FT   VARIANT         36
FT                   /note="G -> W (in a gastric adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040845"
FT   VARIANT         45
FT                   /note="R -> C (in dbSNP:rs56044451)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040846"
FT   MUTAGEN         53
FT                   /note="K->E: Abolished serine/threonine-protein kinase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:29232556"
FT   HELIX           20..23
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   STRAND          24..31
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   STRAND          32..34
FT                   /evidence="ECO:0007829|PDB:4FZD"
FT   STRAND          36..43
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   TURN            44..46
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   STRAND          49..56
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   TURN            58..60
FT                   /evidence="ECO:0007829|PDB:4FZD"
FT   HELIX           61..63
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   HELIX           64..76
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   STRAND          85..91
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   STRAND          94..100
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   STRAND          104..106
FT                   /evidence="ECO:0007829|PDB:3GGF"
FT   HELIX           107..111
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   HELIX           118..137
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   STRAND          138..142
FT                   /evidence="ECO:0007829|PDB:3GGF"
FT   HELIX           147..149
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   STRAND          150..152
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   STRAND          158..160
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   TURN            162..164
FT                   /evidence="ECO:0007829|PDB:4FZD"
FT   TURN            172..174
FT                   /evidence="ECO:0007829|PDB:4FZA"
FT   TURN            176..178
FT                   /evidence="ECO:0007829|PDB:4FZA"
FT   HELIX           188..191
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   HELIX           199..214
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   TURN            218..221
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   HELIX           224..233
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   STRAND          241..243
FT                   /evidence="ECO:0007829|PDB:4FZA"
FT   HELIX           245..254
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   HELIX           259..261
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   HELIX           265..268
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   HELIX           272..277
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   HELIX           282..296
FT                   /evidence="ECO:0007829|PDB:7B36"
FT   STRAND          329..331
FT                   /evidence="ECO:0007829|PDB:5YF4"
FT   HELIX           346..350
FT                   /evidence="ECO:0007829|PDB:3W8I"
FT   HELIX           352..355
FT                   /evidence="ECO:0007829|PDB:4GEH"
FT   HELIX           357..366
FT                   /evidence="ECO:0007829|PDB:4GEH"
FT   TURN            367..370
FT                   /evidence="ECO:0007829|PDB:3W8I"
FT   HELIX           372..391
FT                   /evidence="ECO:0007829|PDB:4GEH"
FT   HELIX           395..409
FT                   /evidence="ECO:0007829|PDB:4GEH"
SQ   SEQUENCE   416 AA;  46529 MW;  3E31B7E3CBDA5768 CRC64;
     MAHSPVAVQV PGMQNNIADP EELFTKLERI GKGSFGEVFK GIDNRTQQVV AIKIIDLEEA
     EDEIEDIQQE ITVLSQCDSS YVTKYYGSYL KGSKLWIIME YLGGGSALDL LRAGPFDEFQ
     IATMLKEILK GLDYLHSEKK IHRDIKAANV LLSEQGDVKL ADFGVAGQLT DTQIKRNTFV
     GTPFWMAPEV IQQSAYDSKA DIWSLGITAI ELAKGEPPNS DMHPMRVLFL IPKNNPPTLV
     GDFTKSFKEF IDACLNKDPS FRPTAKELLK HKFIVKNSKK TSYLTELIDR FKRWKAEGHS
     DDESDSEGSD SESTSRENNT HPEWSFTTVR KKPDPKKVQN GAEQDLVQTL SCLSMIITPA
     FAELKQQDEN NASRNQAIEE LEKSIAVAEA ACPGITDKMV KKLIEKFQKC SADESP
//
